RNA
Atrium Therapeutics Inc
3월 13일 4:00 PM ET (한국 3/14 05:00)
$13.75
-0.79 ▼ -5.43%
🌙 3월 13일 5:57 PM ET (한국 3/14 06:57)
$14.29
+0.54 ▲ +3.93%
| Index | - | P/E | - | EPS (ttm) | - | Insider Own | - | Shs Outstand | - | Perf Week | -7.22% |
| Market Cap | - | Forward P/E | - | EPS next Y | - | Insider Trans | - | Shs Float | - | Perf Month | - |
| Enterprise Value | - | PEG | - | EPS next Q | - | Inst Own | - | Short Float | - | Perf Quarter | - |
| Income | - | P/S | - | EPS this Y | - | Inst Trans | - | Short Ratio | 0.2 | Perf Half Y | - |
| Sales | - | P/B | - | EPS next 5Y | - | ROA | - | Short Interest | 0.43M | Perf YTD | -6.78% |
| Book/sh | - | P/C | - | EPS past 3/5Y | - | ROE | - | 52W High | -18.01% ($16.77) | Perf Year | - |
| Cash/sh | - | P/FCF | - | Sales past 3/5Y | - | ROIC | - | 52W Low | 5.28% ($13.06) | Perf 3Y | - |
| Dividend Est. | - | EV/EBITDA | - | EPS Y/Y TTM | - | Gross Margin | - | Volatility(W/M) | 6.07% - | Perf 5Y | - |
| Dividend TTM | - | EV/Sales | - | Sales Y/Y TTM | - | Oper. Margin | - | ATR (14) | 1.29 | Perf 10Y | - |
| Dividend Ex-Date | - | Quick Ratio | - | EPS Q/Q | - | Profit Margin | - | RSI (14) | - | Recom | 1 |
| Dividend Gr. 3/5Y | - | Current Ratio | - | Sales Q/Q | - | SMA20 | -8.17% ($14.97) | Beta | - | Target Price | $25 |
| Payout | - | Debt/Eq | - | Earnings | 11000000 | SMA50 | -8.17% ($14.97) | Rel Volume | 0.32 | Prev Close | $14.54 |
| Employees | - | LT Debt/Eq | - | EPS/Sales Surpr. | -17.02% 545.33% | SMA200 | -8.17% ($14.97) | Avg Volume(3M) | 2.16M | Price | $13.75 |
| IPO | 2020/6/12 | Option/Short | No/Yes | Trades | 3016 | Volume | 692,357 | Change | -5.43% |
뉴스 로딩 중...